• 대한핵의학회지
• /
• 제37권6호
• /
• pp.341-354
• /
• 2003

Radioactive iodine therapy using I-131 for hyperthyroidism has been used for more than 50 years, and generally considered safe and devoid of major side effects. Appropriate patient selection criteria and clinical judgement concerning patient preparation should be employed for its optimal use. It has not been possible to resolve the trade-off between efficient definite cure of hyperthyroidism and the high incidence of post-therapy hypothyroidism. The dose of the I-131 needed to maintain euthyroid state remains an area of uncertainity and debate. Early side effects are uncommon and readily managable. Other than the need for long-term monitoring and, in most cases, lifelong thyroid hormone treatment for late adverse consequences of this treatment remains only conjectural. We have reviewed general principles and recent advances in radioiodine treatment for Graves' hyperthyroidism, specially regarding to several controversies.

• 한국식품위생안전성학회지
• /
• 제30권1호
• /
• pp.109-114
• /
• 2015

Clostridium perfringens (C. perfringens)와 Mycobacterium fortuitum (M. fortuitum)은 동물과 사람에서 심각한 질병과 관련이 있는 세균들로 알려져 있다. 본 연구에서는, povidone-iodine을 주성분으로 하는 소독제의 살균효과를 C. perfringes와 M. fortuitum을 대상으로 평가하였다. 소독제의 살균효과는 배지희석법을 이용하여, 대상 세균들을 $4^{\circ}C$에서 소독제에 30분 동안 노출시킨 다음, 가장 낮은 소독제의 살균 희석배수를 결정하였다. 소독제는 경수와 유기물로 희석하였으며, 경수 조건에서, C. perfringes와 M. fortuitum에 대해 효과적인 소독제 희석배수는 각각 50과 80배이었다. 유기물 조건에서는, C. perfringes와 M. fortuitum에 대해 효과적인 소독제 희석배수는 모두 15배로 나타났다. 이상의 결과로 부터, povidone-iodine을 주성분으로 하는 소독제는 C. perfringes와 M. fortuitum에 대해 살균효과를 갖는 것으로 확인되었으며, C. perfringes와 M. fortuitum에 의한 질병의 확산을 방지하기 위해 사용될 수 있을 것으로 사료된다.

• 대한방사선기술학회지:방사선기술과학
• /
• 제39권4호
• /
• pp.565-570
• /
• 2016

방사성 요오드($^{131}I$) 치료는 분화성 갑상선암 환자에서 재발을 감소시키고 생존률을 증가시키나, 환자에서 방출되는 방사능으로 인하여 피폭을 야기시킬 수 있으므로 환자로부터 발생되는 방사선량률을 측정하는 것이 방사선안전관리 측면에서 중요하다. 방사성 요오드($^{131}I$) 치료시 널리 사용되는 측정기 중 전리함과 GM계수관으로 측정된 방사선량률의 감도와 측정효율을 구하였다. 방사성 요오드($^{131}I$)를 150mCi 경구투여 받은 분화성 갑상선암 환자의 상복부로부터 1 m거리에서 경과 시간에 따라 방사선량률을 측정하였다. 시간에 따른 변화를 직접적으로 비교한 결과, 고선량률에서의 감도와 측정효율은 GM계수관보다 전리함이 높게 나타났고, 통계적으로 유의하였다(p<0.05). 저선량률에서의 감도와 측정효율은 GM계수관보다 전리함이 낮게 나타났지만 통계적으로 유의한 차이를 나타내지 않았다(p>0.05). 방사성 요오드($^{131}I$) 치료시에 검 교정이 완료된 전리함과 GM계수관으로 정확하고 신속한 방사선량률을 측정하여 환자에게 설명함으로써 방사성 요오드 치료 후 퇴원하는 환자에게 환자가족 또는 주변 사람들에게 미칠 수 있는 방사선피폭을 예측하고, 불필요한 예단을 줄여줄 수 있을 것이다.

• Parasites, Hosts and Diseases
• /
• 제54권1호
• /
• pp.103-107
• /
• 2016

The objective of this study was to evaluate the effects of several different commercial disinfectants on the embryogenic development of Ascaris suum eggs. A 1-ml aliquot of each disinfectant was mixed with approximately 40,000 decorticated or intact A. suum eggs in sterile tubes. After each treatment time (at 0.5, 1, 5, 10, 30, and 60 min), disinfectants were washed away, and egg suspensions were incubated at $25^{\circ}C$ in distilled water for development of larvae inside. At 3 weeks of incubation after exposure, ethanol, methanol, and chlorohexidin treatments did not affect the larval development of A. suum eggs, regardless of their concentration and treatment time. Among disinfectants tested in this study, 3% cresol, 0.2% sodium hypochlorite and 0.02% sodium hypochlorite delayed but not inactivated the embryonation of decorticated eggs at 3 weeks of incubation, because at 6 weeks of incubation, undeveloped eggs completed embryonation regardless of exposure time, except for 10% povidone iodine. When the albumin layer of A. suum eggs remained intact, however, even the 10% povidone iodine solution took at least 5 min to reasonably inactivate most eggs, but never completely kill them with even 60 min of exposure. This study demonstrated that the treatment of A. suum eggs with many commercially available disinfectants does not affect the embryonation. Although some disinfectants may delay or stop the embryonation of A. suum eggs, they can hardly kill them completely.

• 한국환경과학회지
• /
• 제24권12호
• /
• pp.1601-1608
• /
• 2015

This study evaluates heavy metal(Cu and Cr) adsorption characteristics produced from food waste charcoal extracted in an optimal operation condition after analyzing activated charcoal of iodine adsorption and heavy metals that derived from an activation process of carbide by the developed by-products of food waste treatment facility using the methods from previous studies. As experiment apparatus, this study used a tube-shaped high temp furnace. The mixing ratio of by-products of food waste treatment facility, carbide, and activation component($ZnCl_2$) was 1:1. The experiment was proceeded as adjusting the activation temperature from 400 to $800^{\circ}C$ and activation time from 30 to 120 minutes. The optimal activation condition for iodine absorption was 90 minutes at $700^{\circ}C$ and by using the produced food waste charcoal, this study conducted an experiment on absorption of heavy metals (Cu and Cr) as changing pH of artificial wastewater and stirring time. As a result, pH 7 showed the highest heavy metal decontamination ratio and in terms of stirring time, it revealed balance adsorption after 10 minutes. This result can be particularly applied as basic data for recyclability of high concentration organic waste, by-products of food waste treatment facility, as an food waste charcoal.

• 한국방사선학회논문지
• /
• 제6권5호
• /
• pp.373-381
• /
• 2012

방사성옥소를 이용한 갑상선 암의 치료는 지난 수 십년 동안 사용되어 왔으며 많은 치료효과를 보이면서 앞으로 지속적으로 사용되어 질 전망이고 현재 우리나라의 옥소치료병실 수는 2010년 기준 124개의 치료병실이 운영되고 있으나 아직도 부족한 실정이다. 그래서 많은 병원들이 치료병실을 개설하고 있으나 중요한건 치료병실의 수적 증가보단 현재 치료병실의 올바른 관리가 선행되어야 한다는 것이다. 따라서 병실증설에 대한 논의에 앞서 현재 적용되고 있는 치료병실의 안전관리 기준과 일부 대학병원에서 기준으로 삼고 있는 안전관리기준을 조사하여 얼마나 잘 지켜지고 있는지, 치료병실의 이용에 따른 전반적인 안전관리실태여부를 조사하여 고찰 하였다.

• 대한두경부종양학회지
• /
• 제17권2호
• /
• pp.174-178
• /
• 2001

Background and Objective: Percutaneous ethanol injection therapy has been used in the treatment of the benign thyroid diseases. Although the reported side-effects of the therapy was mild and transient, some side-effects including local or radiating pain are troublesome to the patients. Radioactive iodine-131($Ra-^{131}I$) also has been effectively and safely used for management of the benign thyroid diseases. So we developed the percutaneous intranodular injection therapy of $Ra-^{131}I$ as an alternative of percutaneous ethanol injection therapy. Materials and Methods: From December 1998 to October 1999, we treated 29 outpatients (25 women and 4 men, mean age: $47{\pm}12$ years). Inclusion criteria were follows; age >30 years, cytologically benign, with normal thyroid function, cold nodule on thyroid scintigram, solid or mixed natured nodules in sonographical evaluation. Nodular volume was estimated by sonography according to the ellipsoid formula. $Ra-^{131}I$(0.1mCi/ml) was administered in a single dose injection. Follow-up studies every 3 months consisted of full history, thyroid function test, and sonography. We determined the therapeutic response is effective if the volume reduction of the nodule occurred above 30%. Results: After at least 3 months follow-up, 11 patients showed effective response, 12 patients showed minimal or unchanged response and 6 patients showed progression. Although side-effects such as injection pain, febrile reaction, and hormonal changes were absent, an infectious complication in injection site was developed from 1 case. Conclusion: Although we need a more prolonged follow-up to evaluate the delayed sequelae, we can suggest that percutaneous intranodular injection therapy of $Ra-^{131}I$ may be an attractive non-surgical treatment in selected cases of benign thyroid nodules.

• 대한방사선기술학회지:방사선기술과학
• /
• 제33권3호
• /
• pp.269-276
• /
• 2010

본 연구는 고용량 방사성옥소 치료환자의 선량률을 거리와 시간대별로 산출하여 방사성옥소 치료를 위한 입원기간의 최적화와 개선방안을 제한 하고자 하였다. 그 결과 100 mCi 고용량 옥소치료환자의 24시간 후에 배꼽에서 $1,035{\mu}Sv/hr$, 50 cm에서 $109{\mu}Sv/hr$, 100 cm에서 $33{\mu}Sv/hr$로 감쇠 되었다. 150 mCi 고용량 옥소치료환자의 24시간 후에 배꼽에서 $637{\mu}Sv/hr$, 50 cm에서 $100{\mu}Sv/hr$, 100 cm에서 $40{\mu}Sv/hr$로 감쇠 되었다. 180 mCi 고용량 옥소치료환자의 24시간 후에 배꼽에서 $1,251{\mu}Sv/hr$, 50 cm에서 $140{\mu}Sv/hr$, 100 cm에서 $56{\mu}Sv/hr$로 감쇠 되었다. 퇴원기준을 미국 원자력 규제위원회 고시에 $70.4{\mu}Sv/hr$이므로 본 연구 결과보다 빠른 퇴원이 가능하다. 치료 환자들의 계속적인 증가 추세로 볼 때 치료병실의 부족을 해소 할 수 있다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제26권11호
• /
• pp.1577-1582
• /
• 2013

The effects of dietary supplementation of selenium (Se), iodine (I), and a combination of both on the blood haematology, serum free thyroxine (FT4) and free triiodothyronine (FT3) hormones and glutathione peroxidase enzyme (GSH-Px) activity were examined on twenty four (7 to 8 months old, $22{\pm}1.17$ kg live weight) Kacang crossbred male goats. Animals were randomly assigned to four dietary treatments (6 animals in each group). Throughout 100 d of feeding trial, the animals of control group (CON) received a basal diet, while the other three groups were offered basal diet supplemented with 0.6 mg/kg diet DM Se (SS), or 0.6 mg/kg diet DM I (PI), or a combination of both Se and I, each at 0.6 mg/kg diet DM (SSPI). The haematological attributes which are haemoglobin (Hb), red blood cell (RBC), packed cell volume (PCV), mean cell volume (MCV), white blood cells (WBC), band neutrophils (B Neut), segmented neutrophils (S Neut), lymphocytes (Lymph), monocytes (Mono), eosinophils (Eosin) and basophils (Baso) were similar among the four treatment groups, while serum levels of Se and I increased significantly (p<0.05) in the supplemented groups. The combined dietary supplementation of Se and I (SSPI) significantly increased serum FT3 in the supplemented animals. Serum GSH-Px activity increased significantly in the animals of SS and SSPI groups. It is concluded that the dietary supplementation of inorganic Se and I at a level of 0.6 mg/kg DM increased serum Se and I concentration, FT3 hormone and GSH-Px activity of Kacang crossbred male goats.

• 대한두경부종양학회지
• /
• 제14권1호
• /
• pp.61-69
• /
• 1998

Objectives: The response rate of the radioactive iodine(RI) therapy with low dose was variable. Only a few studies reported the response and complication rate with high dose. The goal of this study was to access the ablation and complication rate after high dose of RI therapy (more than 100mCi) and to evaluate the factors affect the results. Material and Methods: During a period of 12 years, 225 patients received high dose of RI from 100 to 200mCi depending on the RI uptake in the whole body after total thyroidectomy. 100mCi of RI was given to 123 patients for ablation who showed the uptake only in the thyroid bed. 150mCi was given to another 84 patients for ablation who had uptake confined to the neck. The other 21 patients took more than 200mCi of RI because the whole body scan showed distant metastasis. Among these patients, the ablation and the complication rate was investigated. Results: Elevated level of the serum thyroglobulin(Tg) decreased less than 5ng/ml after RI therapy in all patients except two in the first group. The second group showed reduction of the serum Tg in 93%. Eighteen of the 21 patients in the third group are still alive after RI therapy. There were no fatal complications after high dose RI therapy and most of the complications were minimal and transient. The complication rate was not related with the dose of RI, age, sex, DNA flowcytometry, serum thyroglobulin level and the extent of node dissection. Conclusion: We concluded that RI therapy with high dose was very effective for thyroid ablation after operation and it also showed excellent results with minimal complications for treatment of metastatic lesions.